Some of the biggest companies in the healthcare industry posted their first-quarter results this past week. Here's what you need to know.
Compounding pharmacies eager to cash in on the peptide boom are watching closely as the nation’s top health official pushes to legalize the market. A regulatory minefield may mean a long wait.
AI-focused biotech Profluent said Tuesday it has entered a multiprogram, strategic research collaboration with Eli Lilly and Co. to treat diseases with high unmet need, in a deal that involves an upfront payment and up to $2.25 billion in additional milestone payments.